The company’s moves come after the FDA seemed to place a new hurdle in the path of psychedelic treatments for mental disorders.
The company’s moves come after the FDA seemed to place a new hurdle in the path of psychedelic treatments for mental disorders.
© 2023 LBNN - All rights reserved.